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Several techniques have been used during the years to treat chondral and osteochondral lesions. Among them, the
emerging trend in the field of osteochondral regeneration is to treat the entire osteochondral unit by implanting
cell-free scaffolds, which provide a three-dimensional support for the cell growth and may act themselves as stimuli for
an “in situ” tissue regeneration. Various multi-layered products have been proposed that mimic both the subchondral
bone and the cartilaginous layer. Among these, three have currently been reported in the literature. One has been
widely investigated: it is a nanocomposite three-layered collagen-hydroxyapatite scaffold, which is showing promising
results clinically and by MRI even at mid-term follow-up. The second is a PLGA-calcium-sulfate bilayer scaffold: however,
the literature findings are still controversial and only short-term outcomes of limited case-series have been published.
The most recent one is a solid aragonite-based scaffold, which seems to give promising clinical and MRI outcomes,
even if the literature is still lacking more in-depth evaluations.
Even though the Literature related to this topic is quickly increasing in number, the clinical evidence it is still limited to
some case series, and high-level studies are needed to better demonstrate their real effectiveness.Introduction
Different techniques have been proposed over the years
for chondral disease, but treating osteochondral disease
is still an arduous challenge for the orthopedic surgeon.
Among the currently available surgical approaches, bone
marrow stimulation procedures aim at favoring the heal-
ing process in the lesion site, taking advantage of the
migration of stem cells from the subchondral bone with
minimal invasiveness and limited costs, even though
paired with well-known limitations (Orth et al. 2012;
Kon et al. 2011b). The surgical alternative traditionally
consists of more aggressive techniques based on autolo-
gous or allogenic tissue transplantation that provides an
immediate viable tissue in the lesion site (Gomoll et al.
2012a; Filardo et al. 2014c). The complexity of cartilage-
bone interface and the differences between cartilage and
subchondral bone layers, including both composition and
biomechanical properties, particularly impede successful
regenerative treatment (Pape et al. 2010; Madry et al.
2010; Orth et al. 2013). However, progress in the field of* Correspondence: e.kon@biomec.ior.it
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in any medium, provided the original work is pbiomaterials has led to a new strategy for the treatment of
such defects of joint articular surface. Based on the ratio-
nale of providing a temporary three-dimensional structure
for the growth of living cells and guide for tissue for-
mation, various biopolymers assembled in the form of a
scaffold have been developed (Kon et al. 2012a). An ideal
scaffold should mimic the biology, architecture, and func-
tional properties of the native tissue, thus promoting cell
attachment, proliferation, and differentiation. Other key
requirements are biocompatibility and biodegradability:
the scaffold should support the early phases of tissue for-
mation and then be gradually replaced by the regenerating
tissue. Following this rationale, such constructs were first
applied in combination with cultured cells (chondrocytes)
such as a 3D support for a better tissue regeneration, thus
producing good results even at mid-long term follow-up
(Filardo et al. 2014b; Brix et al. 2014). Subsequently, this
kind of matrix was applied as “one-step” surgical augmen-
tation to marrow-stimulating techniques, by implanting
into the defect alone, thus avoiding any cell addition
(Anders et al. 2013; Gille et al. 2013), or in combination
with mesenchymal stem cells, harvested and seeded du-
ring the same surgical procedure (Gobbi et al. 2014).
In fact, from a clinical point of view, an ideal graft
should be an off-the-shelf product, thus allowing easyOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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and avoiding problems due to cell manipulation and
culture.
With this in mind and an increasing awareness of the
crucial role of the subchondral bone in the pathogenesis
of articular degeneration, new bi-layered constructs have
been developed to reproduce the different biological and
functional requirements for the growth of both bone and
cartilage tissues, with the aim of providing a treatment to
the entire osteochondral unit. In fact, the above-men-
tioned regenerative techniques showed several limitations
when applied to primary osteochondral defects (i.e.
OCDs) (Filardo et al. 2012a) or articular lesions in a
degenerative context, where the subchondral bone is more
frequently involved (Filardo et al. 2013c; Filardo et al.
2012b). As previously reported, some scaffolds displayed
a potential to act by themselves as stimuli for the differen-
tiation of resident bone marrow stem cells, by inducing
an “in situ” tissue regeneration that allows an orderly
and durable osteochondral tissue without the need for any
cell augmentation (Kon et al. 2012b; O’Shea and Miao
2008; Keeney and Pandit 2009; Lopa and Madry 2014).
Among the many different multi-layered scaffolds spe-
cifically developed to reproduce both bone and cartilage
either with or without the addition of cells (Shimomura
et al. 2014b), only a few acellular ones have currently been
investigated with clinical trials (Table 1). The aim of the
present review is to illustrate the available literature evi-
dence, by focusing on the clinical results obtained with
these osteochondral scaffolds.
Review
Collagen-hydroxyapatite based three-layer scaffold:
MaioRegen™
The most widely studied multi-layered scaffold is
MaioRegen™ (Fin-ceramica, Faenza, Italy), a nanostruc-
tured implant consisting of different ratios of collagen
(coll) and hydroxyapatite (HA) organized in three-layers
(Figure 1; Table 1). The composition of the graft
resembles that of the extracellular matrixes of cartilage
and bone tissue, and is based on nucleation of HA
nanocrystals onto self-assembled coll fibers (Tampieri
et al. 2008) to generate a chemically and morphologically-Table 1 Specifics of the osteochondral scaffolds
Name Trufit CB™ Ma
Number of layers 2 3
Bone phase Ca-sulfate 70%
40%
Cartilage phase Hydrophilic polimer (PGA, PLGA, surfactant) 100
Plug size ∅ 5 - 11 mm cylinders Squ
Plug depth Max 18 mm (to be cut) 6 ±graded biomimetic material. Equine type I coll acts as an
organic matrix for the mineralization process, due to its
good physicochemical stability, processability, high safety
and biocompatibility profile, due to the removal of all
potentially immunogenic telopeptides. The mineral phase
is represented by magnesium–hydroxyapatite (Mg-HA).
Magnesium ions have been introduced to increase the
physicochemical, structural, and morphological affinities
of the composite with natural bone (Serre et al. 1998).
The final design of the scaffold mimics the natural struc-
ture of both cartilage and subchondral bone layers: the
cartilaginous upper layer is smooth on the surface and
consists entirely of Type I coll; the intermediate layer is
made of a combination of Type I coll (60%) and Mg-HA
(40%); and the lower one consists of a mineralized blend
of Type I coll (30%) and Mg-HA (70%). Safety and efficacy
of the product have been shown through preclinical stu-
dies (Kon et al. 2010a; Kon et al. 2010b), where similar re-
sults were obtained with or without loading the implant
with cultured autologous chondrocytes. The scaffold ap-
peared to be able to induce an ordered in situ regene-
ration, possibly through progenitor cells from the bone
marrow surrounding the implantation site, thus allowing
the regeneration of a good quality and well-integrated tis-
sue in the animal model. Moreover, both histological and
immunohistochemical evaluations showed type II coll in
the cartilage region down to the subchondral bone, and
the uniform presence of type I coll in the subchondral
layer, even if aspects of ongoing remodeling were still
present at 6 months (Kon et al. 2010a). These preclinical
findings prompted researchers to bring this method to the
clinical practice as a “cell-free” technique.
The preliminary results of this biomimetic graft were re-
ported in the first clinical trial in 2010 in 13 patients (15
lesions): a high-resolution magnetic resonance imaging
(MRI) evaluation was performed at 5–8 weeks and
6 months after surgery (Kon et al. 2010b), which showed a
complete integration of the implant in 13 of 15 lesions at
5-8 weeks of follow-up, whereas a partial detachment was
found in 2 patients. The 6-month evaluation made with
MOCART (Magnetic Resonance Observation of Cartilage
Repair Tissue) score, showed the ongoing maturation
process, with good filling of the lesion and integration ofioregen™ Agili-C™
2
HA – 30% Coll I Aragonite
HA – 60% Coll I
% Coll I Hyaluronate-impregnated aragonite
are 35 x 35 mm (manual sizing) ∅ 6 - 18 mm cylinders
2 mm (swelling) 15 or 20 mm
Figure 1 HA-Collagene type I three-layer scaffold (Maioregen™,
Finceramica, Italy).
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results of a pilot clinical study at 24 months of follow-up
(Kon et al. 2011a). Twenty-eight consecutive patients
(9 women, 21 men; mean age, 29.3 years) treated for knee
chondral or osteochondral lesions (size 1.5 - 6.0 cm2) im-
proved significantly from baseline to the different follow-
up times in both the International Knee Documentation
Committee (IKDC) and Tegner scores. Further analysis
highlighted a faster recovery for patients with higher pre-
injury activity level, whereas a slower one was found in
patients who presented adverse events, in older ones
or those who had undergone previous surgery, and for
lesions located at the patella. Finally, most of the MRIs
showed complete filling of the cartilage layer and com-
plete integration of the graft. Twenty-seven patients of the
same series (Kon et al. 2014a) were then evaluated for up
to 5 years’ follow-up, where the clinical results recorded at
24 months were confirmed as stable over time up to the
mid-term follow-up. In detail, the IKDC subjective score
improved from 40.0 ± 15.0 to 76.5 ± 14.5 and 77.1 ± 18.0,
and the Tegner score from 1.6 ± 1.1 to 4.0 ± 1.8 and 4.1 ±
1.9 at 2 and 5 years, respectively. MRI evaluation of 23
lesions was also performed at 2 years and at final fol-
low-up, revealing significant improvements in both mean
MOCART score and subchondral bone status over time,
although some abnormalities persisted. However, no
correlation was found between imaging and clinical out-
comes. This biomaterial has also been tested for the
treatment of OCD (osteochondritis dissecans) lesions.
Twenty-seven consecutive patients affected by symptomatic
femoral condyle OCD (average defect size 3.4 ± 2.2 cm2)
were treated and prospectively evaluated by subjective and
objective IKDC and Tegner scores at 2 years’ follow-up. A
statistically significant improvement in all clinical scores
was present at 1 year, and a further improvement was ob-
tained the following year, with no correlation between sizeand outcome. The MRI evaluations showed good defect fill-
ing and implant integration, although most of the scans
presented inhomogeneity of the regenerating tissue and the
presence of subchondral bone alterations. However, even in
this case, no correlation between the MOCART score and
clinical outcome was found (Filardo et al. 2013a). These
positive results suggest that an osteochondral approach is
key for this pathologic entity, which primarily involves the
subchondral bone, and shows good results also for the
treatment of large lesions.
Analogously, Delcogliano et al. obtained an encouraging
outcome at 24 months’ follow-up on 19 patients affected
by large-sized articular defects treated with the same scaf-
fold (Delcogliano et al. 2013), and subsequently demon-
strated positive findings in 49 patients of a multicenter
study, thus supporting the potential of this product also
for the treatment of large osteochondral lesions (Berruto
et al. 2014). Similar results were also reported in a bigger
series of 79 patients affected by femoral condyles or troch-
lea lesions (size 3.2 ± 2.0 cm2) and evaluated prospectively
both clinically and with MRI at 12 and 24 months of
follow-up, where a significantly better outcome was re-
corded in traumatic lesions compared to degenerative
ones (Kon et al. 2014b).
Some encouraging findings have been also documented
by applying this biomimetic approach in cases of “complex”
lesions involving the subchondral bone. A 46-year-old
former athlete (Kon et al. 2009) was successfully treated
by implanting the scaffold in multifocal osteochondral de-
fects of the medial femoral condyle, trochlea and patella,
and concurrently by restoring the correct alignment of a
varus knee through a closing-wedge high tibial osteotomy.
Good clinical outcome and positive MRI results were re-
corded at 12 months’ follow-up. Favourable findings were
reported also in a 50-year-old woman affected by a tibial
plateau osteochondral defect following a Schatzker type II
fracture (Filardo et al. 2009). Due to the complexity of the
lesion, an integrated mechanical and biological approach
was applied to restore the previous anatomic features.
Besides filling the bone and cartilage defect with this
three-layered implant, the tibial plateau was elevated by
an opening-wedge osteotomy and filled with homologous
bone graft, and finally a dynamic external distractor was
applied to allow early mobilization while protecting the
implant. Twelve months later the patient was pain free
and returned to a satisfactory activity level, stable until the
4 years’ follow-up. A further case report dealt with an
Olympic-level female athlete affected by multifocal dege-
nerative knee lesions. The patient underwent a complex
combined treatment: implantation of the scaffold, autolo-
gous osteochondral grafting, patellar realignment, and
meniscal allograft transplantation to address both joint
surface lesions and associated comorbidities. The patient
was able to return to high-level competitions within
Figure 2 Polimeric PLGA-PGA and Calciun sulfate bi-layer scaffold
(Trufit CB™, Smith & Nephew, USA).
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these promising outcomes, obtained through a combined
mechanical and biological approach as a salvage pro-
cedure, a more extensive application was experimented
for complex osteochondral lesions. Thirty-three patients
affected by “complex” knee lesions, according to defined
criteria (Filardo et al. 2013b), were treated by implanting
this multi-layered scaffold and combining concurrent pro-
cedures to address axial misalignment and meniscal resec-
tion sequelae. A good clinical outcome was recorded at
24 months’ follow-up. The clinical results were then com-
pared with those of a homogeneous group of 23 patients
previously treated with a similar protocol but with the im-
plantation of a chondral scaffold. A better outcome was
found in the osteochondral scaffold group. Finally, the
biomimetic scaffold was also tested for the treatment of
unicompartmental OA in young patients (Marcacci et al.
2013), to attempt an alternative solution to metal resur-
facing. Currently, the main surgical indication in a young
and active population affected by unicompartmental OA
consists of unloading osteotomies or unicompartmental
metal resurfacing (Gomoll et al. 2012b), but the high func-
tional demands and the young age of this kind of patient
increase the risk of prosthetic revision. In this challenging
population, characterized by a combination of high
functional demands and great expectations regarding
their recovery on one hand, and a limited choice of
treatment options on the other, a solution to delay or
even avoid metal resurfacing is highly desirable. The
osteochondral scaffold was then implanted in a group of
43 patients affected by unicompartmental OA (Kellegren-
Lawrence < =3), with full-thickness focal cartilage lesions
in stable knees. Concurrent procedures were performed
when required (15 osteotomies, 11 meniscal scaffolds and
9 meniscal allograft implantations). The clinical outcome
showed a significant clinical improvement from pre-op to
the 3 years’ follow-up. The best benefits were obtained in
patients under 40 years old; thus, the authors recom-
mended this surgical approach as a new treatment option
for young OA patients.
A recent study tried to define the best fixation method
for this scaffold, by performing a comparative mechanical
test on a cadaver human knee model (24 scaffolds fixed
only by press-fit, 24 scaffolds by fibrin glue) exposed to
continuous passive motion (CPM). A statistically signi-
ficant difference was obtained between press-fit and fibrin
glue implants with each score used. Whereas scaffolds im-
planted only by a press-fit technique are exposed to de-
formation, delamination, and dislodgement, scaffolds fixed
by fibrin glue showed better layer cohesiveness. Further-
more, implant stability and integrity were maintained even
when load was applied to simulate early weight bearing.
Following these results the authors recommended the use
of fibrin glue in the clinical practice, to improve earlypost-operative stability and integrity of the implant, and
thus allowing a safer and faster recovery (Filardo et al.
2014a).Poli-lactic (PLGA), poli-glycolic acid (PGA), calcium sulfate
biphasic polimer: TruFit™
TruFit™ (Smith & Nephew, Andover, MA) is a bilayer scaf-
fold made of a semiporous 75:25 PLGA-PGA calcium-
sulfate biopolymer, shaped into form by different size
cylinders (Figure 2; Table 1).
The design should allow a complete resorption over
time, which aims to provide a complete filling of the defect
with regenerating tissue (Slivka et al. 2001). Promising pre-
clinical results showed an in vivo good quality of the regen-
erating tissue, with similar gross and histological findings
either with or without the addition of cells (Niederauer
et al. 2000). The scaffold was then introduced into the
clinical practice with the indication to backfill autologous
grafts donor sites, anyway it has been mainly used off-label,
Figure 3 Aragonite-based osteochondral scaffold (Agili-C™,
CartiHeal (2009) Ltd, Israel).
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surface defects, where it showed some controversial re-
sults, although long-term durability evaluations are still
lacking (Melton et al. 2010; Williams and Gamradt 2008).
The first reports described using this scaffold to fill the
donor site during OAT procedures: Bedi et al. (Bedi et al.
2010) found a slow improvement in MRI appearance of
the implant site, whereas Barber et al. documented no
signs of maturation, osteoconduction, or ossification of
the scaffold in any of the 9 patients evaluated with CT
scans (Barber and Dockery 2011). Moreover, Quarch et al.
(Quarch et al. 2014) showed that filling donor site defects
with TruFit™ in patients who underwent OAT, did not
produce clinical improvements since the donor site mor-
bidity was already low anyway.
Other studies reported the application of this bone graft
substitute for the treatment of articular cartilage knee
defects. Also in this case the controversial effectiveness of
this implant was shown. Positive findings were docu-
mented by Carmont et al. in a case report of a sympto-
matic 18-year-old patient treated with this scaffold for a
large chondral lesion on the lateral femoral condyle. The
patient had complete relief of symptoms and was able to
return to sports; moreover, the authors suggested that,
although an intermediate post-operative interval can be
associated with unfavorable MRI findings, the plug ap-
pearance may significantly improve at further follow-up
(Carmont et al. 2009). With quantitative MRI, using de-
layed Gadolinium-enhanced technique, Bekkers et al. eva-
luated the results of 13 patients at a mean of 12 months
after the implantation of this plug in their femoral con-
dyles. These findings were positive both in terms of cli-
nical outcome and cartilage-like signal of the graft in its
superficial layer (Bekkers et al. 2013).
Conversely, other authors documented poor results.
Dhollander et al. (Dhollander et al. 2012) recorded a
failure rate of 20% (3 out of 15 patients) at 1-year
follow-up and biopsies showing fibrous vascularized re-
pair tissue. An even higher number of failures have been
reported when applying this scaffold to patellar defects:
70% of 10 patients treated needed a reoperation due to
implant failure within the first 24 months after surgery
(Joshi et al. 2012); thus, the authors advised against the
use of this scaffold for this kind of lesion. Finally, the
comparison of a group of 35 patients treated with this
scaffold implantation and 31 patients using mosaicplasty
for similar defects, showed significantly higher outcomes
for the latter ones (Hindle et al. 2013).
Crystalline coral aragonite-hyaluronic acid bilayer
scaffold: Agili-C™
The most recent literature describes a novel aragonite-
based osteochondral scaffold applied into clinical prac-
tice (Agili-C™, CartiHeal (2009) Ltd, Israel), developed inshape of cylinders, with a similar surgical rationale than
the mosaic-like osteochondral autograft transplantation.
It is a rigid cell-free implant consisting of two layers: a
bone phase made of calcium carbonate in the aragonite
crystalline form, and a superficial cartilage phase com-
posed of modified aragonite and hyaluronic acid (Figure 3;
Table 1). Preclinical analysis (Kon et al. 2013b) revealed
the safety and potential of this scaffold, thus showing its
biodegradability and intrinsic restorative potential. Par-
ticularly, its ability to recruit cells from the surrounding
tissues, allowed a good regeneration of the entire osteo-
chondral unit to be produced: histological and immuno-
histochemical stainings showed the presence of collagen
type I only in the bone phase and type II in the cartilage
layer. This led to the translation of this scaffold as a one-
step implantation without any cell augmentation into the
clinical setting. Only one case report (Kon et al. 2013a)
describing the clinical use of this construct is currently
available in the literature: a 47-year-old non-professional
sportsman affected by a post-traumatic osteochondral
lesion around 2 cm2 on the medial femoral condyle was
treated successfully and resumed his pre-injury sport
activity after 18 months. The MRI evaluation performed
at 24 months of follow-up showed promising findings
with the restoration of the articular surface.
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The subchondral bone is often involved when the articular
surface is damaged and needs to be treated to have a cor-
rect and durable restoration of the most superficial layers
of the joint. In this context, tissue engineering research has
led to the development of several osteochondral substi-
tutes. Even though the association of several biomaterials
with different cell strategies is being tested preclinically,
these techniques mainly require cell isolation and culture,
as well as two different surgical procedures (Zhang et al.
2013b; Shimomura et al. 2014a; Schleicher et al. 2013b;
Zhang et al. 2013a; Schleicher et al. 2013a; Duan et al.
2013). This is probably one of the reasons why, despite the
favorable results, none of them has already been reported
for the clinical use. In fact, the advantages of these new
biomaterials include also the possibility to perform a one-
step surgical procedure, off-the-shelf availability, a simpler
and faster surgical technique, and lower costs. Among
commercialized scaffolds, three have been documented in
the literature to date. Concerning the polymeric PLGA-
calcium-sulfate bilayer scaffold, the reported results are
quite controversial, both from clinical and imaging points
of view. Conversely, the three-layered scaffold is showing
promising results. Also in this case controversial findings
have been reported from the imaging point of view, but
significant improvements have been repeatedly docu-
mented in the mid-term follow-up, with encouraging out-
comes even for the treatment of complex osteochondral
lesions (including OCDs, large size lesions, unicompart-
mental OA and combined knee injuries), with the pos-
sibility to address also larger articular defects. Thus, this
procedure may be a valid treatment option for osteochon-
dral lesions and a possible solution to delay the need for
more aggressive approaches in “complex” patients. On the
other hand the persistence of an altered signal and a slow
maturation process of the osteochondral unit suggest that
further improvements are still possible to obtain a better
tissue regeneration and an optimal and durable clinical
outcome. Finally, a novel aragonite-based product is show-
ing promising preliminary results, but the literature on this
new product is still limited and it isn’t still available for the
clinical use.
Despite the clinical improvement highlighted by most of
the reported studies for a wide range of indications, some
common controversial findings seem to emerge with regard
to the quality of the regenerative tissue, as testified by alter-
ations in the MRI appearance of the grafts. Experimental
studies are ongoing to test new and different multi-layered
biomaterials and their interaction with cells and the envi-
ronment in an in vivo setting. On the other hand further
clinical studies are needed to assess the real effectiveness of
the available grafts with high level trials, and to better iden-
tify the target of patients which would get most benefit
from these procedures for osteochondral regeneration.Competing interests
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